STUB1 and cardiovascular disorder: Recent studies have indicated that CHIP may be linked to an increased risk of cardiovascular disease (CVD), particularly ischemic CVD, as well as early-onset myocardial infarction, mortality, and rehospitalization [1], suggesting that CHIP promotes a pro-inflammatory state that accelerates disease progression [6].